News
Oppenheimer Initiates Coverage On Immunovant with Outperform Rating, Announces Price Target of $50
28 Mar 24
News, Price Target, Initiation, Analyst Ratings
Truist Securities Reiterates Buy on Immunovant, Maintains $48 Price Target
25 Mar 24
News, Price Target, Reiteration, Analyst Ratings
12 Health Care Stocks Moving In Thursday's Pre-Market Session
21 Mar 24
Movers
Goldman Sachs Initiates Coverage On Immunovant with Buy Rating, Announces Price Target of $50
13 Mar 24
News, Price Target, Initiation, Analyst Ratings
Wolfe Research Initiates Coverage On Immunovant with Outperform Rating, Announces Price Target of $55
15 Feb 24
News, Price Target, Initiation, Analyst Ratings
Recap: Immunovant Q3 Earnings
12 Feb 24
Earnings
Immunovant Q3 EPS $(0.36) Up From $(0.49) YoY, Cash And Cash Equivalents Totaled Approximately $691M
12 Feb 24
Earnings, News